Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Endocrinology

• Publication date

  2008-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ME.2007-0340PMID 17962382PMCID PMC2234590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determinants of Cell- and Gene-Specific Transcriptional Regulation by the Glucocorticoid Receptor

  2007cited by this paper
• Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.

  2007cited by this paper
• Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene.

  2007cited by this paper
• Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

  2006cited by this paper
• A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.

  2006cited by this paper
• Genome-wide analysis of estrogen receptor binding sites

  2006cited by this paper
• Estrogen receptor α and β heterodimers exert unique effects on estrogen- and tamoxifen- dependent gene expression in human U2OS osteosarcoma cells

  2005cited by this paper
• Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.

  2005cited by this paper
• Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.

  2005cited by this paper
• From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.

  2005cited by this paper
• Expanding functional diversity of the coactivators.

  2005cited by this paper
• Ligand control of coregulator recruitment to nuclear receptors.

  2005cited by this paper
• Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells.

  2005cited by this paper
• Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors.

  2004cited by this paper
• Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest.

  2004cited by this paper
• Genome-wide identification of high-affinity estrogen response elements in human and mouse.

  2004cited by this paper
• Identifying estrogen receptor α target genes using integrated computational genomics and chromatin immunoprecipitation microarray

  2004cited by this paper
• Coregulator function: a key to understanding tissue specificity of selective receptor modulators.

  2004cited by this paper
• Selective estrogen receptor modulation: concept and consequences in cancer.

  2004cited by this paper
• Genomic targets of nuclear estrogen receptors.

  2004cited by this paper
• Estrogen Receptor β Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest

  2004cited by this paper
• Selective Estrogen Receptor Modulators

  2004cited by this paper
• Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.

  2003cited by this paper
• Estrogen Receptor-Directs Ordered , Cyclical , and Combinatorial Recruitment of Cofactors on a Natural Target

  2003cited by this paper
• Transcription regulation and animal diversity

  2003cited by this paper
• Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype.

  2003cited by this paper
• MATCHTM: a tool for searching transcription factor binding sites in DNA sequences

  2003cited by this paper
• Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta.

  2003cited by this paper
• Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells.

  2003cited by this paper
• Dragon ERE Finder version 2: a tool for accurate detection and analysis of estrogen response elements in vertebrate genomes

  2003cited by this paper
• TRANSFAC®: transcriptional regulation, from patterns to profiles

  2003cited by this paper
• Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.

  2003cited by this paper
• Estrogen receptor isoform‐specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERα or ERβ

  2003cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• Reciprocal Recruitment of DRIP/Mediator and p160 Coactivator Complexes in Vivo by Estrogen Receptor*

  2002cited by this paper
• Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.

  2002cited by this paper
• Estradiol Represses Human T-cell Leukemia Virus Type 1 Tax Activation of Tumor Necrosis Factor-α Gene Transcription*

  2002cited by this paper
• Molecular Determinants for the Tissue Specificity of SERMs

  2002cited by this paper
• Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites.

  2001cited by this paper
• Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions.

  2001cited by this paper
• Differential SERM activation of the estrogen receptors (ERα and ERβ) at AP-1 sites

  2001cited by this paper
• Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

  2000cited by this paper
• Regulation of keratin 19 gene expression by estrogen in human breast cancer cells and identification of the estrogen responsive gene region.

  2000cited by this paper
• The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.

  1999cited by this paper
• Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

  1999cited by this paper
• Basic guide to the mechanisms of antiestrogen action.

  1998cited by this paper
• Isolation of Estrogen-Responsive Genes with a CpG Island Library

  1998cited by this paper
• Estrogen receptor activation function 1 works by binding p160 coactivator proteins.

  1998cited by this paper
• The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.

  1998cited by this paper
• Molecular basis of agonism and antagonism in the oestrogen receptor

  1997cited by this paper
• Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.

  1997cited by this paper
• Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens.

  1995cited by this paper
• Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens.

  1995cited by this paper
• Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription.

  1991cited by this paper
• Transcription factor interactions: selectors of positive or negative regulation from a single DNA element.

  1990cited by this paper
• An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells.

  1986cited by this paper

• RETRACTED: Lipidic Nano-Sized Emulsomes Potentiates the Cytotoxic and Apoptotic Effects of Raloxifene Hydrochloride in MCF-7 Human Breast Cancer Cells: Factorial Analysis and In Vitro Anti-Tumor Activity Assessment

  2021cites this paper
• Optimized semisolid self-nanoemulsifying system based on glyceryl behenate: A potential nanoplatform for enhancing antitumor activity of raloxifene hydrochloride in MCF-7 human breast cancer cells.

  2021cites this paper
• The guanine nucleotide exchange factor, Spata13, influences social behaviour and nocturnal activity

  2019cites this paper
• Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence

  2015cites this paper
• Identification of a Functional Antioxidant Response Element within the Eighth Intron of the Human ABCC3 Gene

  2015influential citation
• Tamoxifen inhibits ERα positive breast cancer progression by disrupting the ERα-JMJD 2 B signaling axis by Rashi Gupta

  2015cites this paper
• Stromal and epithelial changes in breast cancer following endocrine treatment

  2014cites this paper
• Deciphering the selective androgen receptor modulators paradigm

  2013cites this paper
• Biology and clinical applications of estrogen receptor beta isoforms in endocrine-related cancers

  2013cites this paper
• Sex hormone receptors in breast cancer.

  2013cites this paper
• Estrogen receptor-beta and breast cancer: translating biology into clinical practice.

  2012cites this paper
• Estrogen receptor β potentiates the antiproliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells

  2012cites this paper
• Development of a Novel Molecular Sensor for Imaging Estrogen Receptor-Coactivator Protein-Protein Interactions

  2012influential citation
• Interaction of IGF2 and PTEN in (Malignant) Breast Tissues

  2012cites this paper
• Differential effects of raloxifene and estrogen on body composition in growth hormone-replaced hypopituitary women.

  2012cites this paper
• The enhanced antiproliferative response to combined treatment of trichostatin A with raloxifene in MCF-7 breast cancer cells and its relevance to estrogen receptor β expression

  2012cites this paper
• Inhibitory effects of ERβ on proliferation, invasion, and tumor formation of MCF-7 breast cancer cells-prognostication for the use of ERβ-selective therapy

  2012cites this paper
• XENOSENSOR REGULATION OF ENZYMES AND TRANSPORTERS IN DRUG EXPOSURE AND DISEASE

  2011cites this paper
• Proinflammatory Genes Estrogen Receptors Occurs at a Subset of Cross Talk between Glucocorticoid and

  2011cites this paper
• Estrogen and progesterone receptor expression in HPV-positive and HPV-negative cervical carcinomas.

  2011cites this paper
• Cross Talk between Glucocorticoid and Estrogen Receptors Occurs at a Subset of Proinflammatory Genes

  2011cites this paper
• Genomic Effects of Hormonal Adjuvant Therapies that Could Support the Emergence of Drug Resistance in Breast Cancer

  2010cites this paper
• Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor‐dependent osteoblastic functions in UMR 106 cells

  2010cites this paper
• Signalwege der Östrogenrezeptoren in Knochenzellen

  2010cites this paper
• Unliganded estrogen receptor-beta regulation of genes is inhibited by tamoxifen.

  2010cites this paper
• Selective activation of estrogen receptor-beta target genes by 3,3'-diindolylmethane.

  2010influential citation
• A Role for Sp1 in Transcriptional Regulation of Phosphatidylethanolamine N-Methyltransferase in Liver and 3T3-L1 Adipocytes*

  2010cites this paper
• Selective Activation of Estrogen Receptor- (cid:1) Target Genes by 3,3 (cid:1) -Diindolylmethane

  2010influential citation
• Estrogen Receptor β Binds to and Regulates Three Distinct Classes of Target Genes*

  2010cites this paper
• Drug and Cell Type-Specific Regulation of Genes with Different Classes of Estrogen Receptor β-Selective Agonists

  2009cites this paper
• Identification of Thyroid Hormone Receptor Binding Sites and Target Genes Using ChIP-on-Chip in Developing Mouse Cerebellum

  2009cites this paper
• Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.

  2009cites this paper
• A selective estrogen receptor modulator inhibits TNF-alpha-induced apoptosis by activating ERK1/2 signaling pathway in vascular endothelial cells.

  2009cites this paper
• Improving selective androgen receptor modulator discovery and preclinical evaluation

  2009cites this paper
• Repression of ESR1 through Actions of Estrogen Receptor Alpha and Sin3A at the Proximal Promoter

  2009influential citation
• Is chemoprevention practical?

  2009cites this paper
• Nuclear receptor location analyses in mammalian genomes: from gene regulation to regulatory networks.

  2008cites this paper
• Basic science: (February 2008)

  2008cites this paper
• Mécanismes d'action des composés oestrogéniques dans la neuroprotection chez la souris MPTP = : Neuroprotective mechanisms of estrogenic compounds in MPTP mice

  2008cites this paper
• Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist.

  2008cites this paper
• HER4 Intracellular Domain (4ICD) Activity in the Developing Mammary Gland and Breast Cancer

  2008cites this paper
• Dual role of the arginine methyltransferase CARM1 in the regulation of c‐Fos target genes

  2008cites this paper
• The effects of the selective estrogen receptor modulators MPP and raloxifene in normal and cancerous human and murine uterine tissue

  2007cites this paper